TABLE 3.

Advantages of the Two Proposed Naming Systems for Interchangeable Biologics (2931)

Same Four-Letter SuffixDifferent Four-Letter Suffix
• Less confusion; can mitigate medication errors
• Less resistance to substitution; easier to accept designated status of interchangeability
• Current tracking and safety alert systems can recognize new products
• Easier to track and associate adverse events and/or change in disease to correct product
• Facilitates having accurate records of automatic substitutions (e.g., insurance-mediated switch)
• Lower costs due to marketing competition of different products